This invention provides an application and method of
lysophosphatidylcholine (LPC) in promoting early development of reconstructed embryos, belonging to the field of
embryo engineering technology. The invention first prepares reconstructed embryos, then adds
lysophosphatidylcholine to the culture
system for culturing.
Lysophosphatidylcholine effectively promotes early development of the reconstructed embryos; at an optimal concentration of 5 μM, the
blastocyst development rate increases to 24.56%, providing a novel and operable biochemical intervention target to solve the problem of low reconstructed
embryo culture efficiency. This invention not only fills the gap in our understanding of the
mechanism of action of LPC in this field, but also achieves
controllability and reproducibility of the technical solution through precise definition of the optimal concentration. It provides key parameters for establishing standardized culture procedures and provides a more
solid foundation for downstream applications such as
developmental biology research and
disease model construction that rely on high-quality reconstructed embryos, significantly accelerating the process of related scientific discovery and application development.